Navigation Links
Invest in Cures Forum November 1 Offers Insights, Connections into Impact Investing in Healthcare
Date:10/11/2018

LaunchBio, Inc., a nonprofit organization that identifies, counsels, and supports high-growth, high-impact life science and biotechnology companies, announced today that it will host a forum with investment professionals representing 8 national nonprofit disease foundations to discuss their investment philosophies, explain their fund and deal structures, and describe how they are using deep scientific knowledge to validate early stage technologies and syndicate with other investors.

The program, called Invest in Cures, is scheduled for November 1 from 4-7 p.m. at the North Carolina Biotechnology Center, one of the presenting partners for the forum. North Carolina Biosciences Organization (NCBIO), BioLabs North Carolina, and the Council for Entrepreneurial Development (CED) also are joining LaunchBio as presenting partners for this event.

Nonprofit foundations increasingly are making investments in life science companies to accelerate the pace of commercialization of technologies that may provide new therapies and cures for patients. No longer solely focused on making grants to researchers, disease foundations are creating a range of investment vehicles to achieve their missions.

“We are interested in new sources of capital for early stage life science companies, and see non-traditional investors, such as these foundations, as an important addition to the network,” says Joan Siefert Rose, CEO of LaunchBio. “As disease foundations start venture arms and add investment professionals to their teams, the organizations hosting this forum want to make sure they are meeting other investors and learning about promising companies in North Carolina. Our expectation is that they will find good opportunities here, and return frequently,” she says.

The confirmed speakers for the forum are:

Mark Allegretta, PhD
VP, Commercial Research
National Multiple Sclerosis Society

Jonathan Behr, PhD
Managing Director
T1D Fund, Juvenile Diabetes Research Foundation

Bob Crutchfield
Managing Director
BrightEdge Ventures Fund, American Cancer Society

Gerard Honig, PhD
Manager, Translational Research
IBD Ventures, Crohn’s and Colitis Foundation

Debra Miller
President & CEO
CureDuchenne Ventures

Chris Penland, PhD
Vice President, Biopharma Programs
Cystic Fibrosis Foundation

Barbara Tate, PhD
Venture Partner
Dementia Discovery Fund

Ben Yerxa, PhD
CEO
Retinal Degeneration Fund, Foundation Fighting Blindness

The Invest in Cures forum is part of LaunchBio’s monthly gathering for the biotech community, Larger Than Life Science. Information and registration are available at https://www.launchbio.org/event/invest-in-cures.

About LaunchBio: LaunchBio is a nonprofit organization that identifies, counsels, and supports high-growth, high-impact life science and biotechnology companies. Its mission is to build an ecosystem of innovation for the benefit of human health and well-being.

LaunchBio’s impact is measured by its success in connecting entrepreneurs with knowledge, capital and talent – including each other – not only within geographic regions, but across the nation’s leading life science hubs. LaunchBio offers programs in Durham, NC; San Diego, CA; Boston, MA; and soon will expand to New York City.

Read the full story at https://www.prweb.com/releases/invest_in_cures_forum_november_1_offers_insights_connections_into_impact_investing_in_healthcare/prweb15822470.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. CallTower Continues to Invest in Skype?for Business?for?Companies with Less than?500 Users
2. Clinical Trial Investigates Multicolor Tattoo Removal in Fewer Treatments
3. Plum Alley Closes $1.5M in Syndicate with Women and Men Investing in CRISPR-based Diagnostics Company
4. Global Biometric Vehicle Access System Market 2013-2016 & 2025: $1.58 Billion Growth Opportunities/Investment Opportunities - Research and Markets
5. Strategic Cyber Ventures Leads $3.5M Investment in Polarity
6. Global Military Biometrics Market Growth at 7.5%, 2016-2020 - Technologies Being Used for Local, State & Federal Investigations - Research and Markets
7. Venture Fund with Key Focus on Alzheimers Announces Investment in M3 Biotechnology and Its Drug Aimed at Regrowing Brain Cells
8. License plate reader and historical license plate reader data used in homicide investigation
9. Synaptics to Present at Upcoming Investor Conferences
10. Polygraph Test Now Used to Protect Investors From Fraud
11. Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2019)... Alberta (PRWEB) , ... February 05, 2019 , ... ... (syn-bio) technologies, today announced it has partnered with MindFuel, a leading organization in ... presence in K-12 education. Amino Labs has pioneered a syn-bio starter ...
(Date:1/30/2019)... , ... January 30, 2019 ... ... that identifies, counsels, and supports high-growth, high-impact life science and biotechnology companies, ... 10 national nonprofit disease foundations and disease-focused venture funds to discuss their ...
(Date:1/21/2019)... ... ... Energetiq Technology, a world leader in high brightness broadband light sources, will be ... West events taking place in San Francisco on February 1 – February 7, 2019. ... #941 at Photonics West. There will be live demonstrations of Energetiq’s ultra-bright broadband light ...
Breaking Biology News(10 mins):
(Date:2/22/2019)... ... February 20, 2019 , ... Ocean Tomo Transactions, ... , The patents in lot 92 relate to innovation ... to distinguish between human users and computers through exploiting the fundamental differences between ...
(Date:2/12/2019)... ... 2019 , ... Innovaderm Research, Inc., an innovative clinical research ... of Medrio, the leading provider of eClinical technology for early-phase pharma, medical device, ... customer for over nine years, primarily using the software in Phase I, Phase ...
(Date:2/2/2019)... ... January 31, 2019 , ... Signature ... use of perinatal tissue by applied stem cell research expert and Amazon best-selling ... Cord is a flowable umbilical cord tissue allograft that originates from the same ...
(Date:1/30/2019)... ... January 29, 2019 , ... Mr. Schieving has ... his position as Director of Sales and Marketing, Mr. Schieving was instrumental in ... industries the company supports. During this time, Mr. Schieving was responsible for establishing ...
Breaking Biology Technology: